Cvenkel Barbara
Eye Clinic, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Ophthalmologica. 2004 Jan-Feb;218(1):20-5. doi: 10.1159/000074562.
Selective laser trabeculoplasty (SLT) targets the pigmented trabecular meshwork (TM) cells without damage to the adjacent non-pigmented tissue. A study was conducted to evaluate the efficacy and safety of SLT in the treatment of uncontrolled open-angle glaucoma.
In a prospective non-randomized study 44 eyes of 31 patients with uncontrolled open-angle glaucoma were treated with a frequency-doubled, Q-switched Nd:YAG laser. A total of approximately 50 spots were placed over 180 degrees of the TM at energy levels ranging from 0.7 to 0.9 mJ. Intraocular pressure (IOP) was measured 1, 2, and 24 h, 1 and 2 weeks and 1, 2, 3, 6, 9, and 12 months after treatment.
The average pre-operative IOP was 25.6 (SD 2.6) mm Hg (range 22-34). The mean IOP reduction from baseline at 24 h, 3, 6 and 12 months was 7.1 mm Hg (SD 3.5) or 27.6%; 4.2 mm Hg (SD 3.5) or 16.4%; 4.7 mm Hg (SD 4.2) or 18.6%, and 4.4 mm Hg (SD 3.8) or 17.1%, respectively. The percent of eyes with IOP reduction of 3 mm Hg or more at 3, 6 and 12 months was 66, 78 and 62%. A pressure spike of 8 mm Hg or more was detected in 4 eyes (9.1%). Anterior chamber reaction was seen 1 h after SLT and was mild to moderate in 16 eyes (40.4%) and marked in 3 eyes (6.8%).
SLT has shown reasonable efficacy in lowering IOP over 1-year follow-up, but there was a tendency for IOP to increase with a longer follow-up. Long-term follow-up studies with a large sample size are needed to determine whether the IOP lowering effect is sustained over time, and to assess the efficacy of repeated SLT.
选择性激光小梁成形术(SLT)作用于色素性小梁网(TM)细胞,而不损伤相邻的非色素组织。开展了一项研究以评估SLT治疗未控制的开角型青光眼的疗效和安全性。
在一项前瞻性非随机研究中,对31例未控制的开角型青光眼患者的44只眼使用倍频Q开关Nd:YAG激光进行治疗。在TM的180度范围内共放置约50个光斑,能量水平为0.7至0.9 mJ。在治疗后1、2和24小时、1和2周以及1、2、3、6、9和12个月测量眼压(IOP)。
术前平均IOP为25.6(标准差2.6)mmHg(范围22 - 34)。在24小时、3、6和12个月时,与基线相比平均IOP降低分别为7.1 mmHg(标准差3.5)或27.6%;4.2 mmHg(标准差3.5)或16.4%;4.7 mmHg(标准差4.2)或18.6%,以及4.4 mmHg(标准差3.8)或17.1%。在3、6和12个月时,IOP降低3 mmHg或更多的眼的百分比分别为66%、78%和62%。4只眼(9.1%)检测到8 mmHg或更高的眼压峰值。SLT后1小时可见前房反应,16只眼(40.4%)为轻度至中度,3只眼(6.8%)为重度。
在1年的随访中,SLT在降低IOP方面显示出合理的疗效,但随着随访时间延长有IOP升高的趋势。需要进行大样本量的长期随访研究,以确定IOP降低效果是否随时间持续,并评估重复SLT的疗效。